Vaginal Stump Infection After Laparoscopic Hysterectomy (CoToIn)

October 11, 2022 updated by: Tatiana Naydina Ragaz, Spital Limmattal Schlieren

Vaginal Stump Infection After Total Laparoscopic or Robot-assisted Hysterectomy

Comparing two surgical techniques in relation to vaginal stump infection, analysis of patient-based and therapy-based risk factors.

Study Overview

Detailed Description

Comparing two surgical techniques for vaginal stump infection after total laparoscopic or robot-assisted hysterectomy. Analysis of patient-based and therapy-based risk factors with the aim of optimizing the surgical technique and objectifying the risk factors. Control group: old colpotomy technique (3 Z-sutures PDS 0); Intervention group: new colpotomy technique (3 Z sutures with PDS 0 and 1 continuous suture with V-Loc 2-0)

Study Type

Interventional

Enrollment (Actual)

141

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Kanton Zurich
      • Schlieren, Kanton Zurich, Switzerland, 8952
        • Spital Limmattal

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  1. Patient > = 18 years old
  2. Indication for total laparoscopic or robot-assisted hysterectomy
  3. Benign uterine disease
  4. Signed informed consent for study participation

Exclusion Criteria:

  1. Patient with malignant gynecological diseases
  2. Combination with other abdominal / vaginal interventions, except:

    • Adhesiolysis
    • Endometriosis removal (without rectovaginal endometriosis)
    • Conization
    • Hysteroscopy / curettage
  3. Immunosuppressive therapy with cytostatics, glucocorticoids, HIV
  4. Bleeding tendency / haemophilia
  5. Acute infection

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Arm A (test surgical technique)
Colpotomy closure technique: 3 Z-suture with PDS 0 and 1 continuous suture with V-Loc 2-0
Control group: colpotomy closure technique: 3 Z-sutures PDS 0 Intervention group: colpotomy closure technique: 3 Z sutures with PDS 0 and 1 continuous suture with V-Loc 2-0
ACTIVE_COMPARATOR: Arm B (control surgical technique)
Colpotomy closure technique: 3 Z-suture with PDS 0
Control group: colpotomy closure technique: 3 Z-sutures PDS 0 Intervention group: colpotomy closure technique: 3 Z sutures with PDS 0 and 1 continuous suture with V-Loc 2-0

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of participants with vaginal stump infection in intervention group and control group
Time Frame: 6 weeks

7.-10. day and 6 weeks postoperatively:

  1. T ° C (fever> = 38 ° C)
  2. blood pressure (mm Hg)
  3. general condition (good, reduced, bad)
  4. Speculum examination / condition of the colpotomy:

    • non-irritating / intact
    • dehiscent
    • bleeding
    • fibrin-coated
    • purulent
    • tender
    • hyperemic
    • Infiltrated
    • Fistula formation
  5. Lower abdominal pain (Visual Analog Scale (VAS): 0-10
  6. transvaginal sonography: encapsulated RF on vaginal stump J: ☐N: ☐
  7. Laboratory CRP (> 10mg / L) Hb (<120 g / L) Lc ( >10 G / L)

The diagnosis of vaginal stump infection was made based on 2 of 3 positive clinical symptoms, 1 additional criterion and the corresponding sonographic findings.

I. Clinical symptoms: 1. Fever> = 38 ° C; 2. Dolence, redness, swelling, pus in the colpotomy area; 3. Lower abdominal pain ( VAS >5) II. Sonographic signs (TVUS): encapsulated cystic mass on the vaginal stump Additional criteria: 1. CRP increased (> 10mg / l); 2. Antibiotic therapy needs

6 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Identify of patient-based and treatment-based risk factors for vaginal stump infection.
Time Frame: 6 weeks
connection between Obesity ( BMI >30 kg/ m2), nicotine abuse ( >5 cigarettes/d), anemia ( Hb <120g/L), operation time ( >120min), uterine volume ( >100 cm3) and appearance of vaginal stump infection
6 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Tatiana Naydina Ragaz, Tatiana Naydina Ragaz, Deputy Senior Gynecologist Women's Clinic, Spital Limmattal, Zurich Schlieren

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

August 23, 2018

Primary Completion (ACTUAL)

September 30, 2022

Study Completion (ACTUAL)

September 30, 2022

Study Registration Dates

First Submitted

December 8, 2020

First Submitted That Met QC Criteria

January 22, 2021

First Posted (ACTUAL)

January 27, 2021

Study Record Updates

Last Update Posted (ACTUAL)

October 13, 2022

Last Update Submitted That Met QC Criteria

October 11, 2022

Last Verified

October 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • BASEC-Nr.2018-00777

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Vaginal Infection

Clinical Trials on Total laparoscopic hysterectomy

Subscribe